Lantern Pharma
Price & Volume
Stats
See more52W Range | $1.11-$4.70 |
Market Cap | $26.9M |
Shares Short | 846,372 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.49 |
News
See moreYahoo Finance • 13 days ago
Lantern Pharma outlines Open Medicine AI spin-out amid $10B market outlook by 2030-2031
Yahoo Finance • 3 months ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Yahoo Finance • 5 months ago
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Yahoo Finance • 6 months ago
Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition
About
CEO | Mr. Panna Sharma |
CFO | Mr. David R. Margrave |
Address | 1920 McKinney Avenue, Dallas, TX, United States, 75201 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |